Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to $18.7 million.

  • Dare Bioscience's Cash from Financing Activities rose 417322.45% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year increase of 21864.94%. This contributed to the annual value of $433830.0 for FY2024, which is 9722.56% down from last year.
  • Per Dare Bioscience's latest filing, its Cash from Financing Activities stood at $18.7 million for Q3 2025, which was up 417322.45% from -$43794.0 recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Cash from Financing Activities registered a high of $35.2 million during Q3 2021, and its lowest value of -$132012.0 during Q4 2024.
  • Over the past 5 years, Dare Bioscience's median Cash from Financing Activities value was $875785.0 (recorded in 2023), while the average stood at $6.2 million.
  • In the last 5 years, Dare Bioscience's Cash from Financing Activities soared by 53092690000.0% in 2023 and then crashed by 13796.09% in 2025.
  • Over the past 5 years, Dare Bioscience's Cash from Financing Activities (Quarter) stood at $16.0 million in 2021, then tumbled by 100.0% to -$1.0 in 2022, then soared by 530926900.0% to $5.3 million in 2023, then plummeted by 102.49% to -$132012.0 in 2024, then soared by 14227.68% to $18.7 million in 2025.
  • Its last three reported values are $18.7 million in Q3 2025, -$43794.0 for Q2 2025, and $246577.0 during Q1 2025.